1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Delineating the intra-patient heterogeneity of molecular alterations in treatment-naïve colorectal cancer with peritoneal carcinomatosis
(
- Contribution to journal › Article
- 2021
-
Mark
Clinical significance of RBM3 expression in surgically treated colorectal lung metastases and paired primary tumours
(
- Contribution to journal › Article
- 2017
-
Mark
High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
(
- Contribution to journal › Article